Abstract: A medicant injection device includes a compressible body, a tip, and an outer luer body. The compressible body has a proximal end, a distal end, and a plurality of bellows, and defines an inner cavity for holding a liquid medicant. The tip is positioned at the proximal end of the compressible body. The outer luer body includes internal threads, and is positioned over and engaged with the tip to form a first fitting therewith. The first fitting is configured to be connected with a second fitting. A medicant injection device includes a compressible body having first and second arms, a receptacle interconnected with the compressible body and defining an inner cavity, and a first fitting configured to engage a second fitting. The compressible body is configured to be compressed by forcing the distal end of the first and second arm toward each other.

Abstract: A drip chamber is described that is used in medical infusion therapy, wherein the drip chamber utilizes valving to control flow of one or more fluids to a patient. The drip chamber includes a body forming a chamber, wherein fluid may enter via two or more flow ports, and an output port, where fluid may exit the chamber. A float controls fluid flow through one or more flow ports into the chamber such that the flow exiting the chamber may be limited to a single fluid or a combination of the fluids entering the chamber. The float is configured to be retained within the chamber, and the float moves within the chamber based on a level of fluid within the chamber. The control characteristics of the float are determinable by attributing specific buoyancy and dimensions to the float.

Abstract: The present disclosure relates to devices and methods for increasing the probability of a successful organ donation by decreasing organs' warm ischemia time. Furthermore, the present disclosure relates to increasing the pool of eligible donors, including donors who had prior chest surgeries or prior abdominal surgeries. The present disclosure provides a catheter extending through a cannula, wherein the cannula delivers cold perfusion fluid and the catheter blocks the aorta, forcing the cold perfusion fluid to pass to organs in the donor's abdomen. The present disclosure further provides for advancing the catheter from a retracted position to an extended position, and creating a watertight seal at the cannula to prevent backflow of cold perfusion fluid.

Abstract: A suction instrument includes a proximal end, a distal end configured to be positioned within or adjacent to an anatomical passageway of a patient, and a suction lumen extending between the proximal and distal ends. The suction lumen is configured to provide suction at the distal end. A navigation sensor is disposed along a portion of the suction lumen and is operable to generate an electrical signal corresponding to a location of the portion within the patient. A coupling feature is disposed at the proximal end and is configured to releasably couple the proximal end with a body.

Abstract: Disclosed herein are devices and methods for delivering a predetermined volume of a drug substance or other product including a fluid. An exemplary device may include a body configured to receive a drug substance therein, and a plunger rod disposed at least partially inside the body to distally move a stopper in the body. The device may include a component configured to regulate distal movement of the plunger rod in a priming step and in a subsequent delivery step, so that the device may be accurately primed and may accurately dispense a predetermined volume of a drug substance.

Abstract: A device, system and method are provided for controlling the rate of infusion of fluids during infusion therapy using non-electric infusion devices. Rotation of a flow regulator dial causes an orifice connected to the inlet to modify its position relative to a particular one or more orifices or groove portions, the characteristics of which provide a certain flow rate characteristic. The flow regulator allows for the infusion pump to infuse at a rate that may be varied during use by the user. Additionally, the flow regulator is made from a material selected to operate under a wide range of pressures, from 5-40 PSI, making the flow regulator compatible with pressurized devices, such as, a non-electric pump.

Abstract: The present disclosure provides a method of removing a cover from a bodily surface of a subject. The method may comprise applying a cover removal device to a portion of the cover that is disposed on the bodily surface of the subject, thereby generating a connection between the cover removal device and the portion of the cover. The method may comprise moving the cover removal device across the bodily surface of the subject in order to selectively remove the cover from the bodily surface and capture the cover onto the cover removal device, without the cover removal device substantially affecting or interfering with the bodily surface of the subject.

Abstract: An implant injection device, includes an injection needle, a receiver housing for receiving at least one implant, injection device, including a pushing rod, arranged upstream from the implant housed in the receiver housing, and configured to push the implant through the injection needle between an initial position and a final position, a pushing member for pushing the pushing rod between the initial position and the final position, a retaining member for retaining the pushing rod by friction relative to the injection needle, opposing the displacement of the pushing rod to its final position, it being possible for a user to actuate the retaining member.

Abstract: A stabilization device for integrated catheters can include a platform, a pair of catheter fasteners on the platform, and a pair of stabilization wings extending from the platform. The platform can include a skin-facing side and catheter-securing side of the platform. The pair of catheter fasteners can be on the catheter-securing side of the platform. The catheter fasteners can be configured to secure a hub of an integrated catheter having an extension port. The pair of stabilization wings can extend from a transverse axis of the platform. The stabilization wings can be configured to mitigate rotation of the integrated catheter about a longitudinal axis thereof when the integrated catheter is secured by the catheter fasteners on the platform and the stabilization device is adhered to a patient. A method for stabilizing integrated catheters can include securing an integrated catheter and adhering the stabilization device to a patient's skin.

Abstract: A device for securing a catheter, or similar flexible medical tube or medical device to the skin of a patient. The device comprises a planar body (1) at least a lock retainer (5) and a passive retainer (6), both spaced-apart from each other. Furthermore a method of securing a catheter to a patient using a device as described.

Abstract: An IV catheter system may include a catheter component with a catheter hub, a cannula extending distally from the catheter hub, and a securement platform. The securement platform may include a wing, which may extend from the catheter hub. The IV catheter system may also include a needle component with a needle hub, a needle extending distally from the needle hub along an axis, and a grip extending from the needle hub. The grip may be generally parallel to the axis and disposed on a side of the needle hub. The wing and the grip may be positioned to facilitate manipulation with a single hand to move the IV catheter system from an insertion configuration towards a fluid delivery configuration.

Abstract: An apparatus includes a handle assembly, a guide member extending distally from the handle assembly, and a dilation catheter slidably disposed relative to the guide member. The dilation catheter includes an expandable element configured to dilate a paranasal sinus ostium of a patient. A navigation sensor is movably disposed at the distal end of the guide member and is operable to generate a signal corresponding to a location thereof within the patient. The navigation sensor is configured to translate distally with the dilation catheter relative to the guide member when a distal end of the dilation catheter translates distally beyond the distal end of the guide member. The navigation sensor is further configured to assume a position at the distal end of the guide member when the distal end of the dilation catheter retracts proximally of the distal end of the guide member.

Abstract: A method and a drug delivery system for transdermally administering parathyroid hormone (PTH) in a pulsatile fashion are provided, where the drug delivery system comprises an array of microprojections each comprising PTH.

Abstract: An attachment for a device for generating an air flow or dispensing a fluid, which attachment is designed to be at least partially introduced into an external auditory canal of a human or animal ear, the attachment including a connection piece for connecting the attachment to the device for generating an air flow, and a tongue-type guide vane for conducting air that flows out of the device for generating an air flow via the connection piece, the guide vane having a bottom.

Abstract: A system, method, and apparatus for rapid transdermal disinfection includes a processor or equivalent that generates a series of pulses having pulse widths limited to less than two microseconds. The pulses are amplified to a direct-current voltage of between 150 volts and 500 volts and connected to a positive electrode for attaching to an animal. A negative electrode for attaching to the animal is electrically connected to a current limiter for limiting electrical current flow between the positive electrode and the negative electrode to between 0.2 amps and 2 amps.

Abstract: A treatment system includes a guide, tubular dilator members, an operation portion, and a holding portion. The guide extends linearly or curvilinearly. The dilator members pass the guide inside and are configured to move forward along the guide. The operation portion is configured to sequentially move the plurality of dilator members from a proximal end side of the guide to a distal end side of the guide. The holding portion is provided on the guide. A distance between outer edges of the holding portion in a direction intersecting a direction from the proximal end side toward the distal end side of the guide is larger or is configured to be larger than a distance between outer edges of the guide.

Abstract: An injector includes a housing and an activation button assembly movably mounted thereto and translatable from an unactuated position to an actuated position. A cartridge door is configured to receive therein a cartridge containing a substance to be dispensed, and is movably mounted to the injector housing between open and closed positions. A deflectable interference member is mounted within the injector housing and, in a resting position, blocks movement of the activation button assembly from the unactuated to the actuated position thereof. The activation button assembly is configured to activate the injector when in the actuated position, and is movable from the unactuated position to the actuated position solely upon deflection of the interference element out of the resting position thereof. The cartridge door, when in the closed position thereof and having the cartridge received therein, deflects the interference element out of the resting position thereof.

Abstract: The present disclosure relates to devices and systems for targeted and controlled delivery of a therapeutic agent to a treatment site of an eye. Particularly, aspects are directed to a therapeutic agent delivery device that includes a polymeric substrate having a release region, a delivery region, and a receiving region; one or more reservoirs formed within the release region; a therapeutic agent disposed within the one or more reservoirs; an active, passive, or combination thereof controlled release mechanism for release of the therapeutic agent from the one or more reservoirs into the delivery region; and a circuit formed on the polymeric substrate, the circuit having a current source, a first iontophoresis electrode located within the delivery region for transport of the therapeutic agent from the delivery region into a target tissue via electromigration, and a second iontophoresis electrode located within the receiving region for maintaining electroneutrality within the tissue.

Abstract: A sutureless chest tube adhesion assembly configured to quickly and easily anchor a chest tube is described. The assembly generally comprises a notched flexible substrate adapted to adhere to human skin 415. A chest tube incision in a notched region of the substrate provides an entry point for the chest tube which is anchored to the substrate by way of an intermediate flexible membrane that covers and adheres to the chest tube and substrate. The intermediate flexible membrane has a matching notched region adapted to accommodate the chest tube. The chest tube and incision are adapted to be covered by a transparent cover sheet which covers and adheres to a portion of the substrate, the intermediate flexible membrane and to a portion of the human skin 415.

Abstract: Insertion devices, systems, and methods for inserting a needle into a target tissue in an individual in need thereof are disclosed herein. Also disclosed herein are needle cartridges comprising a needle, a plate, and a needle holder. Also disclosed herein are methods of introducing a catheter into a target tissue in an individual in need thereof.